Low-dose methotrexate to treat mycosis fungoides: a retrospective study in 69 patients - 29/08/11
, Mohammed Kashani-Sabet, MD a, Alex McMillan, PhD bAbstract |
Background |
Although low-dose methotrexate has been used to treat mycosis fungoides for many years, documentation is very limited.
Objective |
Our purpose was to review our experience with methotrexate in the treatment of 69 patients with patch/plaque and tumor stage mycosis fungoides observed for up to 201 months.
Methods |
This was a retrospective study. Data are presented in terms of response rates and time to treatment failure.
Results |
The greatest number of patients (60) had patch/plaque stage T2 disease (≥10% skin involved). Of these, 7 (12%) achieved complete remission and 13 (22%) achieved partial remission for a total response rate of 20 of 60 (33%). The median time to treatment failure was 15 months. Only 1 of 7 patients with tumor stage disease responded. Side effects caused treatment failure in 6 (9%) of the total cohort of 69 patients.
Conclusion |
Low-dose methotrexate may be of value in the treatment of a subset of patients with patch/plaque mycosis fungoides resistant to other therapies.
Le texte complet de cet article est disponible en PDF.Plan
 | Supported by the Herschel and Diana Zackheim Endowed Fund (Dr Kashani-Sabet). Conflicts of interest: None identified. |
Vol 49 - N° 5
P. 873-878 - novembre 2003 Retour au numéro
Article précédent
- PTEN expression in normal skin, acquired melanocytic nevi, and cutaneous melanoma
- Hensin Tsao, Martin C Mihm, Christine Sheehan
- Pulsed dye laser treatment of thick/raised vascular lesions using compression with clear plastic
- Michael J Boffa
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?